Naxitamab treatment of refractory/relapsed high-risk neuroblastoma (R/R HR NB); Subgroup analysis of updated interim efficacy and safety data for the registrational phase II trial Meeting Abstract
| Authors: | Mora, J.; Bear, M.; Chi-Fung Chan, G.; Morgenstern, D.; Nysom, K.; Tornoe, K.; Losic, N.; Kushner, B. |
| Abstract Title: | Naxitamab treatment of refractory/relapsed high-risk neuroblastoma (R/R HR NB); Subgroup analysis of updated interim efficacy and safety data for the registrational phase II trial |
| Meeting Title: | 53rd Congress of the International Society of Paediatric Oncology (SIOP) |
| Journal Title: | Pediatric Blood and Cancer |
| Volume: | 68 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Oct 21-24 |
| Meeting Location: | Virtual |
| ISSN: | 1545-5009 |
| Publisher: | Wiley Periodicals, Inc |
| Date Published: | 2021-11-01 |
| Start Page: | S85 |
| Language: | English |
| ACCESSION: | WOS:000708132100171 |
| PROVIDER: | wos |
| PUBMED: | 34662504 |
| DOI: | 10.1002/pbc.29349 |
| Notes: | Meeting Abstract: O0171 / #679 -- Source: Wos |
